P-184 A phase 2 trial of trastuzumab deruxtecan (T-DXd, DS-8201) in patients with HER2-positive, unresectable or metastatic gastric or gastroesophageal junction adenocarcinoma
作者
Charles S. Fuchs,Javad Shahidi,Lijoy K. Mathew,Ailing Qin,Eric Van Cutsem